Correspondencia
Enfermedad de Castleman, VIH y rituximab
Castleman's disease, HIV and rituximab
M.E. Valencia
, V. López, M.T. Corcuera, D. Del Val
Hospital Carlos III, Madrid, España
Leído
589
Vecesse ha leído el artículo
589
Total PDF
0
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 6 | 0 | 4 | 4 |
| 2025 5 | 0 | 12 | 12 |
| 2025 4 | 0 | 18 | 18 |
| 2025 3 | 0 | 33 | 33 |
| 2025 2 | 0 | 24 | 24 |
| 2025 1 | 0 | 22 | 22 |
| 2024 12 | 0 | 21 | 21 |
| 2024 11 | 0 | 24 | 24 |
| 2024 10 | 0 | 25 | 25 |
| 2024 9 | 0 | 22 | 22 |
| 2024 8 | 0 | 18 | 18 |
| 2024 7 | 0 | 19 | 19 |
| 2024 6 | 0 | 37 | 37 |
| 2024 5 | 0 | 16 | 16 |
| 2024 4 | 0 | 14 | 14 |
| 2024 3 | 0 | 25 | 25 |
| 2024 2 | 0 | 13 | 13 |
| 2024 1 | 0 | 20 | 20 |
| 2023 12 | 0 | 20 | 20 |
| 2023 11 | 0 | 22 | 22 |
| 2023 10 | 0 | 48 | 48 |
| 2023 9 | 0 | 16 | 16 |
| 2023 8 | 0 | 15 | 15 |
| 2023 7 | 0 | 52 | 52 |
| 2023 6 | 0 | 31 | 31 |
| 2023 5 | 0 | 18 | 18 |
Mostrar todo
